Literature DB >> 6894571

Selective binding of sucralfate to gastric ulcer in man.

S Nakazawa, R Nagashima, I M Samloff.   

Abstract

Sucralfate is a basic aluminum salt of a sulfated disaccharide. In this study, patients with gastric ulcer were given oral multiple doses of sucralfate prior to partial gastrectomy, and binding of the drug to the ulcer lesion and to nonulcerated mucosa was estimated by chemical determination of aluminum and sulfated disaccharide. The ulcerated mucosa was found to contain, on the average, 6-7 times more sucralfate per square centimeter than the control mucosa (P less than 0.01 and less than 0.05 for aluminum and sulfated disaccharide, respectively). The high affinity of sucralfate for ulcerated mucosa, particularly the sucrose sulfate moiety, supports previous data that the beneficial effect of sucralfate in ulcer disease is due in part to complex formation between sucrose sulfate and proteins at the ulcer site.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6894571     DOI: 10.1007/bf01308368

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  12 in total

1.  A controlled clinical trial of Sucralfate in the treatment of gastric ulcer.

Authors:  J F Mayberry; R A Williams; J Rhodes; B W Lawrie
Journal:  Br J Clin Pract       Date:  1978-10

2.  Mechanism of the antipeptic action of anionic carbohydrate and its clinical application for the treatment of peptic ulcer.

Authors:  A Ishimori
Journal:  Tohoku J Exp Med       Date:  1971-02       Impact factor: 1.848

3.  Sucralfate, a basic aluminum salt of sucrose sulfate. III. Inhibition of peptic hydrolysis of fibrinogen by sucrose sulfate.

Authors:  N Terao; N Yoshida; R Nagashima
Journal:  Arzneimittelforschung       Date:  1980

4.  Sucralfate, a basic aluminum salt of sucrose sulfate. II. Inhibition of peptic hydrolysis as it results from sucrose sulfate interaction with protein substrate, serum albumins.

Authors:  R Nagashima; N Yoshida; N Terao
Journal:  Arzneimittelforschung       Date:  1980

5.  Sucralfate, a basic aluminum salt of sucrose sulfate. I. Behaviors in gastroduodenal pH.

Authors:  R Nagashima; N Yoshida
Journal:  Arzneimittelforschung       Date:  1979

6.  Comparison of sucralfate with cimetidine in the short-term treatment of chronic peptic ulcers.

Authors:  I N Marks; J P Wright; M Denyer; J A Garisch; W Lucke
Journal:  S Afr Med J       Date:  1980-04-12

7.  Endoscopic evaluation of the effect of sucralfate therapy and other clinical parameters on the recurrence rate of gastric ulcers.

Authors:  T Miyake; J Ariyoshi; T Suzaki; M Oishi; M Sakai; S Ueda
Journal:  Dig Dis Sci       Date:  1980-01       Impact factor: 3.199

8.  Sucralfate, a basic aluminum salt of sucrose sulfate. IV. Interaction with enzyme pepsin.

Authors:  N Yoshida; N Terao; R Nagashima
Journal:  Arzneimittelforschung       Date:  1980

9.  Sucralfate in the treatment of duodenal ulcers: a double-blind endoscopically controlled trial.

Authors:  M G Moshal; J M Spitaels; F Khan
Journal:  S Afr Med J       Date:  1980-05-03

10.  Selective binding of sucralfate to ulcer lesion. III. Experiments in rats with duodenal ulcer receiving 14C-sucralfate.

Authors:  R Nagashima; Y Hinohara; T Hirano
Journal:  Arzneimittelforschung       Date:  1980
View more
  18 in total

1.  Long-term maintenance therapy with sucralfate.

Authors:  M C Allison
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

2.  Effect of bismuth subcitrate and sucralfate on rat duodenal and human gastric bicarbonate secretion in vivo.

Authors:  C J Shorrock; A Garner; A H Hunter; J R Crampton; W D Rees
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

3.  Effect of sucralfate and its components on taurocholate-induced damage to rat gastric mucosal cells in tissue culture.

Authors:  M Romano; M Razandi; K J Ivey
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

4.  Sucralfate reduces the gastrointestinal absorption of norfloxacin.

Authors:  S H Parpia; D E Nix; L G Hejmanowski; H R Goldstein; J H Wilton; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

Review 5.  [The use of sucralfate in radiation oncology].

Authors:  C Belka; W Hoffmann; F Paulsen; M Barnberg
Journal:  Strahlenther Onkol       Date:  1997-05       Impact factor: 3.621

6.  Effect of intragastric pH on mucosal protective action of sucralfate.

Authors:  J Z Danesh; A Duncan; R I Russell; G Mitchell
Journal:  Gut       Date:  1988-10       Impact factor: 23.059

7.  Stimulation of amphibian gastroduodenal bicarbonate secretion by sucralfate and aluminium: role of local prostaglandin metabolism.

Authors:  J R Crampton; L C Gibbons; W D Rees
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

8.  Utilization of a human intestinal epithelial cell culture system (Caco-2) for evaluating cytoprotective agents.

Authors:  A S Tang; P J Chikhale; P K Shah; R T Borchardt
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

9.  A novel evaluation method of gastric mucoadhesive property in vitro and the mucoadhesive mechanism of tetracycline-sucralfate acidic complex for eradication of Helicobacter pylori.

Authors:  Shoichi Higo; Kazutomo Ori; Hirofumi Takeuchi; Hiromitsu Yamamoto; Tomoaki Hino; Yoshiaki Kawashima
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

10.  Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth.

Authors:  Michael Fannon; Kimberly Forsten-Williams; Matthew A Nugent; Kalvin J Gregory; Chia Lin Chu; Adrienne L Goerges-Wildt; Dipak Panigrahy; Arja Kaipainen; Carmen Barnes; Cathy Lapp; Yuen Shing
Journal:  J Cell Physiol       Date:  2008-05       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.